Science Explorer Back to mapMap
Discussion

Maxygen (United States)

In research, Maxygen (United States) stands highest in Life Sciences (#7,325 of 11,023 worldwide), over all time.

World rank, all time
#30,185
of 34,923
Rank in United States
#6,365
of 7,310
Research works
235
▲ 175% vs 2018-21
Citations
23k
98.1 per fractional work
Top-10% rate
8.9%
all institutions 10.0%
vs its own fields
1.24×
1.00× is exactly expected
Open access
31%
world 40%
International
19%
world 18%

What is Maxygen (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
Life SciencesDomain #7,325 of 11,023 18.9%145

Each strip is that field's whole ranked pool, with the notch where Maxygen (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which fields of science does Maxygen (United States) work in?

In all years, 62% of research at Maxygen (United States) is in Life Sciences, 26% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (45%), Medicine (25%), Immunology and Microbiology (11%). It does 3.9× the world's share of Life Sciences.

Life Sciences: 145 fractional works · 61.8% of its workBiochemistry, Genetics and Molecular Biology: 105 fractional works · 44.6% of its workMolecular Biology: 75 fractional works · 31.9% of its workGenetics: 9 fractional works · 3.8% of its workCell Biology: 6 fractional works · 2.7% of its workBiotechnology: 6 fractional works · 2.6% of its workCancer Research: 6 fractional works · 2.5% of its workBiophysics: 1 fractional works · 0.3% of its workAging: 1 fractional works · 0.3% of its workBiochemistry: 1 fractional works · 0.2% of its workImmunology and Microbiology: 25 fractional works · 10.6% of its workImmunology: 21 fractional works · 9.1% of its workVirology: 3 fractional works · 1.2% of its workMicrobiology: 1 fractional works · 0.3% of its workNeuroscience: 7 fractional works · 2.9% of its workCellular and Molecular Neuroscience: 5 fractional works · 2.0% of its workDevelopmental Neuroscience: 1 fractional works · 0.6% of its workSmaller subfields together: 1 fractional works · 0.3% of its workAgricultural and Biological Sciences: 6 fractional works · 2.7% of its workPlant Science: 5 fractional works · 2.1% of its workInsect Science: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 2 fractional works · 1.0% of its workToxicology: 1 fractional works · 0.5% of its workPharmaceutical Science: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Sciences: 60 fractional works · 25.6% of its workMedicine: 58 fractional works · 24.6% of its workOncology: 16 fractional works · 6.7% of its workRadiology, Nuclear Medicine and Imaging: 10 fractional works · 4.1% of its workImmunology and Allergy: 4 fractional works · 1.6% of its workHematology: 3 fractional works · 1.2% of its workPulmonary and Respiratory Medicine: 2 fractional works · 1.0% of its workEpidemiology: 2 fractional works · 1.0% of its workPublic Health, Environmental and Occupational Health: 2 fractional works · 1.0% of its workSurgery: 2 fractional works · 0.9% of its workInfectious Diseases: 2 fractional works · 0.7% of its workPharmacology: 2 fractional works · 0.7% of its workEndocrinology, Diabetes and Metabolism: 2 fractional works · 0.6% of its workPathology and Forensic Medicine: 1 fractional works · 0.6% of its workPhysiology: 1 fractional works · 0.6% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.5% of its workGenetics: 1 fractional works · 0.5% of its workHepatology: 1 fractional works · 0.4% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 0.4% of its workNeurology: 1 fractional works · 0.3% of its workObstetrics and Gynecology: 1 fractional works · 0.3% of its workEmergency Medicine: 0 fractional works · 0.2% of its workOphthalmology: 0 fractional works · 0.2% of its workSmaller subfields together: 3 fractional works · 1.1% of its workHealth Professions: 2 fractional works · 0.8% of its workGeneral Health Professions: 1 fractional works · 0.3% of its workEmergency Medical Services: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.2% of its workDentistry: 1 fractional works · 0.3% of its workOral Surgery: 1 fractional works · 0.3% of its workPhysical Sciences: 24 fractional works · 10.4% of its workEngineering: 8 fractional works · 3.3% of its workBiomedical Engineering: 3 fractional works · 1.3% of its workMedia Technology: 1 fractional works · 0.5% of its workCivil and Structural Engineering: 1 fractional works · 0.4% of its workElectrical and Electronic Engineering: 1 fractional works · 0.3% of its workMechanical Engineering: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.5% of its workChemistry: 6 fractional works · 2.4% of its workOrganic Chemistry: 4 fractional works · 1.6% of its workSpectroscopy: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.3% of its workEnvironmental Science: 5 fractional works · 2.1% of its workHealth, Toxicology and Mutagenesis: 2 fractional works · 0.8% of its workEcology: 2 fractional works · 0.7% of its workEnvironmental Chemistry: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 2 fractional works · 1.1% of its workComputational Theory and Mathematics: 1 fractional works · 0.5% of its workArtificial Intelligence: 1 fractional works · 0.3% of its workComputer Science Applications: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 2 fractional works · 0.9% of its workMaterials Chemistry: 2 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPhysics and Astronomy: 1 fractional works · 0.3% of its workEarth and Planetary Sciences: 0 fractional works · 0.2% of its workEnergy: 0 fractional works · 0.1% of its workMathematics: 0 fractional works · 0.0% of its workSocial Sciences: 5 fractional works · 2.1% of its workSocial Sciences: 3 fractional works · 1.1% of its workPolitical Science and International Relations: 2 fractional works · 0.8% of its workSmaller subfields together: 1 fractional works · 0.3% of its workBusiness, Management and Accounting: 1 fractional works · 0.4% of its workEconomics, Econometrics and Finance: 1 fractional works · 0.3% of its workEconomics and Econometrics: 1 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPsychology: 1 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 0.1% of its workALL ITS WORKMaxygen (UnitedStates)235fractional works, all years
Life Sciences62%Physical Sciences10%Health Sciences26%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology10544.6%
    2. Immunology and Microbiology2510.6%
    3. Neuroscience72.9%
    4. Agricultural and Biological Sciences62.7%
    5. Pharmacology, Toxicology and Pharmaceutics21.0%
    1. Medicine5824.6%
    2. Health Professions20.8%
    3. Dentistry10.3%
    1. Engineering83.3%
    2. Chemistry62.4%
    3. Environmental Science52.1%
    4. Computer Science21.1%
    5. Materials Science20.9%
    6. Physics and Astronomy10.3%
    7. Earth and Planetary Sciences00.2%
    8. Energy00.1%
    9. Mathematics00.0%
    1. Social Sciences31.1%
    2. Business, Management and Accounting10.4%
    3. Economics, Econometrics and Finance10.3%
    4. Psychology10.3%
    5. Arts and Humanities00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.49× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.50× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 7.72× its world share, 1 worksImmunology and Micro…Neuroscience: 1.61× its world share, 0 worksNeuroscienceChemistry: 1.66× its world share, 0 worksChemistryEarth and Planetary Sciences: 0.28× its world share, 0 worksEarth and Planetary …Engineering: 0.38× its world share, 1 worksEngineeringEnvironmental Science: 0.04× its world share, 0 worksEnvironmental ScienceDentistry: 8.05× its world share, 1 worksDentistryHealth Professions: 0.68× its world share, 0 worksHealth ProfessionsMedicine: 1.76× its world share, 6 worksMedicineBusiness, Management and Accounting: 0.30× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.60× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.82× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Dentistry, 8.1×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Dentistry8.05×1 works
  2. Immunology and Microbiology7.72×1 works
  3. Biochemistry, Genetics and Molecular Biology4.50×4 works
  4. Medicine1.76×6 works
  5. Chemistry1.66×0 works
  6. Neuroscience1.61×0 works
  7. Economics, Econometrics and Finance1.60×1 works
  8. Social Sciences0.82×2 works
  9. Health Professions0.68×0 works
  10. Agricultural and Biological Sciences0.49×0 works
  11. Engineering0.38×1 works
  12. Business, Management and Accounting0.30×0 works
  13. Earth and Planetary Sciences0.28×0 works
  14. Environmental Science0.04×0 works

Who are the top researchers at Maxygen (United States)?

Ranked on the quality score, Bahija Jallal, Gerald McMahon and Laura K. Shawver lead among researchers whose main affiliation is Maxygen (United States).

  1. 1 Bahija Jallal United States · #172,407 worldwide 8.1k citations · 140 works
  2. 2 Gerald McMahon United States · #221,308 worldwide 16k citations · 115 works
  3. 3 Laura K. Shawver United States · #225,168 worldwide 7.1k citations · 103 works
  4. 4 Willem P.C. Stemmer United States · #815,295 worldwide 9.3k citations · 67 works
  5. 5 Steven R. Leong United States · #1,034,970 worldwide 3.3k citations · 42 works
  6. 6 Harald App United States · #1,097,230 worldwide 3.3k citations · 21 works
  7. 7 Beverly D. Smolich United States · #1,196,209 worldwide 2.2k citations · 18 works
  8. 8 Mikhail L. Gishizky United States · #1,225,933 worldwide 3.6k citations · 40 works
  9. 9 Emari L. Mann United States · #1,800,830 worldwide 953 citations · 18 works
  10. 10 Cho Tang United States · #2,061,659 worldwide 7.1k citations · 42 works
All ranked researchers at Maxygen (United States)

What are the most cited papers from Maxygen (United States)?

The most cited paper from Maxygen (United States) is "In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship." (Dirk B. Mendel et al., 2003), with 1,971 citations. Next come "High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis" (1,957) and "Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions" (1,420).

Most cited papers
#PaperReleasedCitations
1 In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic/pharmacodynamic relationship. Dirk B. Mendel et al. · PubMed 2003 1,971
2 High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis Birgit Millauer, Susanne Wizigmann-Voos, Harald Schnürch et al. · Cell Mar 1993 1,957
3 Protein tyrosine kinase PYK2 involved in Ca2+-induced regulation of ion channel and MAP kinase functions Sima Lev, Herman Moreno, Ronny Martínez et al. · Nature Aug 1995 1,420
4 Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant Birgit Millauer, Laura K. Shawver, Karl Heinz Plate et al. · Nature Feb 1994 1,234
5 A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers James Robert Bischoff, Lee Anderson, Yingfang Zhu et al. · The EMBO Journal Open access Jun 1998 1,226
All 60 most cited papers, with filters and sorting

Which keywords describe research at Maxygen (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Cancer, Glycosylation, Cancer Therapy, Monoclonal Antibodies, Therapeutic Antibodies, Antibody Engineering, Fc Receptors and Autoimmunity.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer26▲ 7.8×26 topics
  2. Glycosylation14▲ 28×3 topics
  3. Inflammation12▲ 2.1×23 topics
  4. Cancer Therapy12▲ 7.8×8 topics
  5. Monoclonal Antibodies10▲ 29×3 topics
  6. Therapeutic Antibodies9▲ 31×2 topics
  7. Antibody Engineering9▲ 39×1 topic
  8. Fc Receptors9▲ 39×1 topic
  9. Autoimmunity9▲ 18×3 topics
  10. Transcriptional Regulation7▲ 12×7 topics
  11. Cancer Immunotherapy7▲ 22×3 topics
  12. Tumor Microenvironment7▲ 8.6×5 topics
  13. Antigen Presentation7▲ 30×2 topics
  14. Cell Signaling7▲ 8.8×8 topics
  15. Angiogenesis7▲ 7.2×8 topics
  16. Stem Cells7▲ 9.8×9 topics
  17. Innate Immunity7▲ 8.1×7 topics
  18. Metabolism7▲ 4.4×14 topics
  19. Vascular Endothelial Growth Factor7▲ 28×2 topics
  20. Chemotherapy6▲ 3.9×8 topics
  21. Immune Response6▲ 4.5×6 topics
  22. Genome Engineering6▲ 47×1 topic
  23. RNA-Guided6▲ 47×1 topic
  24. Mutation6▲ 17×4 topics
  25. TGF-ß6▲ 16×3 topics
  26. VEGF6▲ 77×1 topic
  27. endothelial progenitor cells6▲ 77×1 topic
  28. CD4+CD25+6▲ 34×1 topic
  29. Foxp36▲ 34×1 topic
  30. Immunity6▲ 7.5×3 topics
  31. Biopharmaceuticals6▲ 34×3 topics
  32. Dendritic Cells5▲ 20×1 topic
  33. Tumor Antigen5▲ 28×1 topic
  34. Monoclonal Antibody5▲ 32×2 topics
  35. NK Cell Recognition5▲ 22×1 topic
  36. Natural Killer Cells5▲ 22×1 topic
  37. Recombinant Proteins5▲ 41×2 topics
  38. Cell Migration5▲ 24×2 topics
  39. Extracellular Matrix5▲ 8.4×5 topics
  40. Plant Molecular Farming5▲ 83×1 topic

Which research topics does Maxygen (United States) publish most on?

By volume in 2022-now: Muscle Physiology and Disorders, E-Government and Public Services, Cancer Immunotherapy and Biomarkers and Tissue Engineering and Regenerative Medicine.

  1. 1 Muscle Physiology and Disorders Molecular Biology 1 works
  2. 2 E-Government and Public Services Political Science and International Relations 1 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
  4. 4 Tissue Engineering and Regenerative Medicine Surgery 1 works
  5. 5 CAR-T cell therapy research Oncology 1 works
  6. 6 Immunotherapy and Immune Responses Immunology 0 works
  7. 7 Immune Cell Function and Interaction Immunology 0 works
  8. 8 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
  9. 9 Microbial Inactivation Methods Biotechnology 0 works
  10. 10 Cancer Genomics and Diagnostics Cancer Research 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.1%not open68.9%

World: 40% of research is openly available.

with international co-authors19.2%domestic only80.8%

World: 18% is written across borders.

How has Maxygen (United States)'s research output changed?

Output in 2022-2025 was 175% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Maxygen (United States) as a percentage of every work published that year, 0.000043% in 2024.

still counting0.0010%0.0020%0.0030%Maxygen (United States)0.000052% in 202519801990200020102020

Fractional works of Maxygen (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Redwood City

All research institutions in Redwood City

Share Maxygen (United States)'s ranking

Maxygen (United States) on Science Explorer

A card with Maxygen (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Maxygen (United States). Posts are plain text and can be reported.